Eliminating Cervical Cancer: the Impact of Screening and Human Papilloma Virus Vaccination.
作者信息
Nabi Samah, Mimba Brenda-Ruth, Akunne Ogochukwu
机构信息
Morehouse School of Medicine, 720 Westview Dr SW, Atlanta, GA 30310 (
Morehouse School of Medicine. Atlanta, Georgia.
出版信息
Prev Chronic Dis. 2025 Jul 24;22:E46. doi: 10.5888/pcd22.250127.
Abstract
摘要
相似文献
1
Eliminating Cervical Cancer: the Impact of Screening and Human Papilloma Virus Vaccination.消除宫颈癌：筛查与人乳头瘤病毒疫苗接种的影响
Prev Chronic Dis. 2025 Jul 24;22:E46. doi: 10.5888/pcd22.250127.
2
Cost effectiveness of human papilloma virus vaccination in low and middle income countries: a systematic review of literature.中低收入国家人乳头瘤病毒疫苗接种的成本效益：文献系统评价。
Expert Rev Vaccines. 2018 Jan;17(1):91-98. doi: 10.1080/14760584.2018.1411195. Epub 2017 Dec 6.
3
Investigating factors affecting the effectiveness of Gardasil 4, Cervarix, and Gardasil 9 vaccines considering the WHO regions in females: A systematic review.考虑世界卫生组织各区域因素，调查加德西4价、卉妍康和加德西9价疫苗在女性中的有效性：一项系统评价。
Cancer Epidemiol. 2025 Apr;95:102759. doi: 10.1016/j.canep.2025.102759. Epub 2025 Feb 5.
4
The efficacy of vaccination to prevent human papilloma viruses infection at anal and oral: a systematic review and meta-analysis.疫苗接种预防肛门和口腔人乳头瘤病毒感染的效果：系统评价和荟萃分析。
Public Health. 2021 Jul;196:165-171. doi: 10.1016/j.puhe.2021.05.012. Epub 2021 Jul 3.
5
The Cost-Effectiveness of the Human Papilloma Virus Vaccination in Asia Pacific Countries: What Lessons Can Indonesia Learn?-A Systematic Review.亚太国家人乳头瘤病毒疫苗接种的成本效益：印度尼西亚能吸取哪些教训？-一项系统综述
Vaccines (Basel). 2025 May 30;13(6):593. doi: 10.3390/vaccines13060593.
6
Realising the promise of HPV vaccination - data from the national cervical screening and vaccination registers demonstrates the impact of HPV vaccination in Aotearoa New Zealand.实现人乳头瘤病毒（HPV）疫苗接种的前景——来自国家宫颈癌筛查和疫苗接种登记处的数据表明了HPV疫苗接种在新西兰的影响。
J R Soc N Z. 2025 Mar 3;55(5):1271-1283. doi: 10.1080/03036758.2025.2458028. eCollection 2025.
7
[Improving the coverage rate of human papillomavirus vaccine among adolescent females to contribute to the goal of eliminating cervical cancer in China].提高青春期女性人乳头瘤病毒疫苗接种率以助力中国消除宫颈癌目标
Zhonghua Yu Fang Yi Xue Za Zhi. 2025 Jul 16;59:1-6. doi: 10.3760/cma.j.cn112150-20250630-00610.
8
Integrating HPV vaccination programs with enhanced cervical cancer screening and treatment, a systematic review.将人乳头瘤病毒（HPV）疫苗接种计划与强化宫颈癌筛查及治疗相结合：一项系统评价
Vaccine. 2022 Mar 31;40 Suppl 1:A116-A123. doi: 10.1016/j.vaccine.2021.11.013. Epub 2021 Dec 1.
9
HPV DNA screening and vaccination strategies in Tunisia.突尼斯的人乳头瘤病毒DNA筛查与疫苗接种策略
Sci Rep. 2025 Jul 31;15(1):27916. doi: 10.1038/s41598-025-13423-3.
10
The Study of the Prevalence of Knowledge and Vaccination Status of HPV Vaccine Among Healthcare Students at a Tertiary Healthcare Center in Western India.印度西部一家三级医疗中心医学生人乳头瘤病毒（HPV）疫苗知识普及程度及接种状况研究
J Obstet Gynaecol India. 2024 Aug;74(4):326-333. doi: 10.1007/s13224-023-01891-4. Epub 2024 Jan 2.
引用本文的文献
1
Students Having Their Say: Novel Approaches and Solutions to Current and Emerging Public Health Problems.学生们各抒己见：应对当前及新出现的公共卫生问题的新方法与解决方案。
Prev Chronic Dis. 2025 Aug 21;22:E54. doi: 10.5888/pcd22.250252.
本文引用的文献
1
Advances and Challenges in Cervical Cancer: From Molecular Mechanisms and Global Epidemiology to Innovative Therapies and Prevention Strategies.宫颈癌的进展与挑战：从分子机制、全球流行病学到创新疗法与预防策略
Cancer Control. 2025 Jan-Dec;32:10732748251336415. doi: 10.1177/10732748251336415. Epub 2025 Apr 23.
2
Identifying the key barriers, facilitators and factors associated with cervical cancer screening attendance in young women: A systematic review.确定与年轻女性宫颈癌筛查参与率相关的关键障碍、促进因素和因素：一项系统评价。
Womens Health (Lond). 2025 Jan-Dec;21:17455057251324309. doi: 10.1177/17455057251324309. Epub 2025 Mar 13.
3
Advances in cervical cancer: current insights and future directions.宫颈癌的进展：当前见解与未来方向
Cancer Commun (Lond). 2025 Feb;45(2):77-109. doi: 10.1002/cac2.12629. Epub 2024 Nov 29.
4
Impact of the COVID-19 pandemic on HPV vaccine uptake in a predominantly Hispanic Border Community: A retrospective cross-sectional analysis of the "Tiempo de Vacunarte Program".2019年冠状病毒病大流行对一个以西班牙裔为主的边境社区人乳头瘤病毒疫苗接种率的影响：“Tiempo de Vacunarte计划”的回顾性横断面分析
Arch Public Health. 2024 Jun 24;82(1):96. doi: 10.1186/s13690-024-01318-0.
5
Barriers to cervical cancer prevention in a safety net clinic: gaps in HPV vaccine provider recommendation and series completion among Ob/Gyn patients.安全网诊所中宫颈癌预防的障碍：妇产科患者人乳头瘤病毒疫苗接种建议及全程接种率方面的差距
Front Oncol. 2024 Mar 28;14:1359160. doi: 10.3389/fonc.2024.1359160. eCollection 2024.
6
Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2022.13-17 岁青少年疫苗接种覆盖率-美国全国免疫调查青少年，2022 年。
MMWR Morb Mortal Wkly Rep. 2023 Aug 25;72(34):912-919. doi: 10.15585/mmwr.mm7234a3.
7
Disrupted Routine Medical Visits in Children and Adolescents During the COVID-19 Pandemic, January-June 2021.2021年1月至6月新冠疫情期间儿童和青少年常规医疗就诊中断情况
AJPM Focus. 2023 Jun 8;2(4):100119. doi: 10.1016/j.focus.2023.100119.
8
Stigma, social support, and spirituality: associations with symptoms among Black, Latina, and Chinese American cervical cancer survivors.污名、社会支持和精神信仰：与黑种人、拉丁裔和华裔美国宫颈癌幸存者症状的关联。
J Cancer Surviv. 2024 Jun;18(3):710-726. doi: 10.1007/s11764-022-01283-z. Epub 2022 Nov 22.
9
Effects of mobile Health (mHealth) application on cervical cancer prevention knowledge and screening among women social support groups with low-socioeconomic status in Mysuru city, Southern India.印度南部迈索尔市社会经济地位较低的女性社交群体中，移动医疗 (mHealth) 应用对宫颈癌预防知识和筛查的影响。
PLoS One. 2022 Sep 1;17(9):e0273070. doi: 10.1371/journal.pone.0273070. eCollection 2022.
10
HPV Vaccination Uptake, Hesitancy, and Refusal: Observations of Health-Care Professionals During the COVID-19 Pandemic.HPV 疫苗接种率、犹豫和拒绝：COVID-19 大流行期间医护专业人员的观察。
JNCI Cancer Spectr. 2022 Jul 1;6(4). doi: 10.1093/jncics/pkac053.
Zotero 插件